ANEB - Anebulo Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.56 0.19 (7.42%)	---	---	0.05 (1.85%)	---	0.16 (6.25%)	0.05 (1.85%)	0.05 (1.85%)

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.04
Diluted EPS:: -0.04
Basic P/E:: -68.75
Diluted P/E:: -68.75
RSI(14) 1m:: 100.0
VWAP:: 2.71
RVol:: 1.2469

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.75 +0.05 (+1.85%)	Oct 15 16:37
10m	Price increase 10m	2.7 +0.1 (+3.85%)	Oct 15 15:56
60m	Price increase 60m	2.7 +0.14 (+5.47%)	Oct 15 15:56
1m	Price decrease 1m	2.53 -0.07 (-2.7%)	Oct 15 15:27
1m	Price increase 1m	2.6 +0.03 (+1.17%)	Oct 15 15:23